Medical cannabis authorization and risk of emergency department visits and hospitalization due to psychotic disorders: A propensity score-matched cohort study
Dubois C, Lunghi C, Eurich DT, Dyck JRB, Hyshka E, Hanlon JG, Zongo A., Schizophr Res., 2024
COVID-19 vaccination among young people who use drugs in Vancouver, Canada
McAdam E, Hayashi K, Barker B, Reddon H, Choi J, Kerr T, DeBeck K., Vaccine. 2024
Facteurs associés à l’initiation fréquente de la buprénorphine / naloxone dans une enquête nationale auprès des médecins d’urgence canadiens
MacKinnon N, Lane D, Scheuermeyer F, Kaczorowski J, Dong K, Orkin AM, Daoust R, Moe J, Andolfatto G, Klaiman M, Yan J, Koh JJ, Crowder K, Atkinson P, Savage D, Stempien J, Besserer F, Wale J, Kestler A.,
Author Reply to Letter to the Editor in Response to “Fentanyl Concentration in Drug Checking Samples and Risk of Overdose Death in Vancouver, Canada”
Kennedy MC, Tobias S, Dong H, Buxton JA, Lysyshyn M, Tupper KW, Ti L., Am J Prev Med. 2024
Stigma-related barriers to medical cannabis as harm reduction for substance use disorder: Obstacles and opportunities for improvement
Fehr F, Lo LA, Nelson C, Nanson K, Diehl L, Nielson K, Reddon H, Walsh Z., Int J Ment Health Nurs. 2024
A qualitative assessment of tablet injectable opioid agonist therapy (TiOAT) in rural and smaller urban British Columbia, Canada: Motivations and initial impacts
Bowles J, Mansoor M, Werb D, Kerr T, Bardwell G., J Subst Use Addict Treat. 2024
Using alone at home: What’s missing in housing-based responses to the overdose crisis?
Fleming T, Boyd J, Chayama KL, Knight KR, McNeil R., Reduct J. 2024
Initiation à faible dose de buprénorphine/naloxone pour la gestion de la douleur chronique non cancéreuse chez les patients sous traitement à long terme aux opioïdes : une série de cas
Rattanavong M, Kwan D, Jorgenson D, Landry E, Marwah R, Halpape K., Can J Pain., 2024
Trajectoires de la consommation d’opioïdes comme prédicteurs des résultats rapportés par les patients chez les personnes fréquentant des cliniques multidisciplinaires de traitement de la douleur
Angarita-Fonseca A, Lacasse A, Choinière M, Kaboré JL, Sylvestre MP, Dinkou GDT, Bruneau J, Martel MO, Hovey R, Motulsky A, Rahme E, Pagé MG, Drug Saf. 2024
Associations between Gender Expression, Protective Coping Strategies, Alcohol Saliency, and High-Risk Alcohol Use in Post-Secondary Students at Two Canadian Universities
Bahji A, Boonmak P, Koller M, Milani C, Sutherland C, Horgan S, Chen SP, Patten S, Stuart H., Int J Environ Res Public Health., 2024
